Insights

Global Export Capabilities Tedec Meiji Farma actively exports medicines to multiple international markets, including America and Asia, indicating strong global distribution channels that can be leveraged for expanding sales and entering new regions.

Rich Product Portfolio The company produces high-demand pharmaceutical products such as third-generation cephalosporins and hyaluronic acid-based treatments, presenting opportunities to collaborate on complementary or emerging healthcare solutions.

Award-Winning Performance Recognized with the Outstanding Performance Award in 2023, Tedec Meiji Farma demonstrates operational excellence and industry recognition, which can foster trust and strengthen sales relationships with prospective clients.

Strategic Innovation Focus With dedicated research, development, and innovation centers, the company is well-positioned to partner in innovative healthcare projects and new drug developments, opening avenues for joint ventures or licensing deals.

Growing Revenue Range Generating between $10 million and $25 million, Tedec Meiji Farma presents significant growth potential within the pharmaceutical sector, suggesting ample opportunity for expanding sales through targeted outreach to healthcare providers and distributors.

Similar companies to Meiji Pharma Spain, S.A.

Meiji Pharma Spain, S.A. Tech Stack

Meiji Pharma Spain, S.A. uses 8 technology products and services including WordPress, oEmbed, jQuery, and more. Explore Meiji Pharma Spain, S.A.'s tech stack below.

  • WordPress
    Content Management System
  • oEmbed
    Dev Tools
  • jQuery
    Javascript Libraries
  • imagesLoaded
    Javascript Libraries
  • Google Maps
    Maps
  • OVHcloud
    Platform As A Service
  • Contact Form 7
    Web Platform Extensions
  • Nginx
    Web Servers

Meiji Pharma Spain, S.A.'s Email Address Formats

Meiji Pharma Spain, S.A. uses at least 2 format(s):
Meiji Pharma Spain, S.A. Email FormatsExamplePercentage
F.Last@tedecmeiji.comJ.Doe@tedecmeiji.com
84%
Last@tedecmeiji.comDoe@tedecmeiji.com
11%
First.Last@tedecmeiji.comJohn.Doe@tedecmeiji.com
5%

Frequently Asked Questions

What is Meiji Pharma Spain, S.A.'s phone number?

Minus sign iconPlus sign icon
You can contact Meiji Pharma Spain, S.A.'s main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Meiji Pharma Spain, S.A.'s official website and social media links?

Minus sign iconPlus sign icon
Meiji Pharma Spain, S.A.'s official website is meiji.es and has social profiles on LinkedIn.

What is Meiji Pharma Spain, S.A.'s NAICS code?

Minus sign iconPlus sign icon
Meiji Pharma Spain, S.A.'s NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Meiji Pharma Spain, S.A. have currently?

Minus sign iconPlus sign icon
As of December 2025, Meiji Pharma Spain, S.A. has approximately 252 employees across 3 continents, including EuropeAsiaNorth America. Key team members include Presidente & Ceo: R. G. N.Business Development Director: L. F.Director De Recursos Humanos: M. F. G.. Explore Meiji Pharma Spain, S.A.'s employee directory with LeadIQ.

What industry does Meiji Pharma Spain, S.A. belong to?

Minus sign iconPlus sign icon
Meiji Pharma Spain, S.A. operates in the Pharmaceutical Manufacturing industry.

What technology does Meiji Pharma Spain, S.A. use?

Minus sign iconPlus sign icon
Meiji Pharma Spain, S.A.'s tech stack includes WordPressoEmbedjQueryimagesLoadedGoogle MapsOVHcloudContact Form 7Nginx.

What is Meiji Pharma Spain, S.A.'s email format?

Minus sign iconPlus sign icon
Meiji Pharma Spain, S.A.'s email format typically follows the pattern of F.Last@tedecmeiji.com. Find more Meiji Pharma Spain, S.A. email formats with LeadIQ.

Meiji Pharma Spain, S.A.

Pharmaceutical ManufacturingCommunity of Madrid, Spain201-500 Employees

Quiénes somos:

Meiji Pharma Spain, S.A. es un laboratorio farmacéutico perteneciente a un grupo multinacional, con sede y plantas de fabricación en Alcalá de Henares (Madrid). Fundada en 1991 como filial de Meiji Seika Pharma Co. Ltd., división farmacéutica del grupo japonés Meiji Holdings Co., Ltd., la compañía representa un proyecto consolidado que se materializa en unas instalaciones diseñadas para cumplir con las exigencias regulatorias de la industria farmacéutica, tanto a nivel nacional como internacional.

La compañía cuenta con una destacada presencia en el mercado español, respaldada por un sólido compromiso en materia de actividad industrial, comercial e inversión en I+D+i. En su sede de Alcalá de Henares, dispone de dos plantas de fabricación, un centro de investigación, desarrollo e innovación, un centro logístico y las oficinas centrales destinadas al personal administrativo.

Desde España, Meiji Pharma Spain, S.A. exporta medicamentos a países de todo el mundo y fabrica productos para otras compañías farmacéuticas con presencia multinacional. Sus instalaciones son un referente dentro del Grupo Meiji, siendo responsables de la producción de dos de sus productos más relevantes: una cefalosporina de tercera generación y un producto a base de ácido hialurónico, destinados tanto al mercado nacional como a mercados internacionales, incluidos el americano y el asiático.

En Meiji Pharma Spain, S.A. estamos comprometidos con la mejora de la salud. Contamos con un experimentado equipo a la vez que seguimos empleando recursos para poder hacer llegar nuestros productos a todos los pacientes del mundo.

Misión:

En Meiji Phara Spain trabajamos para contribuir activamente en la mejora de la salud y bienestar de las personas en el mundo. Nuestra misión es acercar una salud más humana, accesible y consciente a cada persona, combinando la excelencia científica con una profunda vocación de cuidado.

Section iconCompany Overview

Phone number
Website
meiji.es
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
201-500

Section iconFunding & Financials

  • $10M$25M

    Meiji Pharma Spain, S.A.'s revenue is estimated to be in the range of $10M$25M

Section iconFunding & Financials

  • $10M$25M

    Meiji Pharma Spain, S.A.'s revenue is estimated to be in the range of $10M$25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.